What is SmithRX?
SmithRX operates as a high-growth healthcare technology firm specializing in the modernization of pharmacy benefit management. By utilizing a 100% pass-through pricing model and proprietary cloud-native software, the company effectively reduces drug costs while enhancing health outcomes for employers and their members. Its platform, SmithRX Connect, serves as a critical bridge between clinical programs and alternative sourcing, simplifying the complex prescription benefits ecosystem. With a dual-headquarters presence in California and Utah, the firm is uniquely positioned to disrupt legacy PBM incumbents through its commitment to radical transparency and seamless integration with existing TPA and broker networks.
How much funding has SmithRX raised?
SmithRX has raised a total of $89.3M across 4 funding rounds:
Series A
$9M
Debt
$350K
Series B
$20M
Series C
$60M
Series A (2018): $9M with participation from NextGen Venture Partners, Blumberg Capital, and Box Group
Debt (2020): $350K led by PPP
Series B (2022): $20M supported by Venrock and Founders Fund
Series C (2024): $60M featuring Venrock
Key Investors in SmithRX
Venrock
A historic venture capital firm based in Palo Alto, Venrock specializes in partnering with founders to build high-growth technology and healthcare companies through deep industry expertise.
Founders Fund
A prominent venture capital firm known for its founder-friendly investment strategy, backing transformative companies across various sectors and stages of development.
Box Group
An early-stage investment fund that focuses on innovative technology companies, providing critical support to startups in the fintech and software sectors.
What's next for SmithRX?
Looking ahead, SmithRX is poised to leverage its recent capital to deepen its technological moat and broaden its market reach. The strategic focus will likely center on scaling its cloud infrastructure to accommodate a growing roster of enterprise clients while further refining its clinical program offerings. By maintaining its founder-centric approach and commitment to cost-efficiency, SmithRX is well-positioned to capture additional market share in the evolving digital health sector. Future initiatives will likely prioritize the integration of advanced data analytics to further optimize pharmacy spend and improve member engagement, ensuring the company remains at the forefront of the PBM innovation curve.
See full SmithRX company page
